Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer
Interventions: DRUG: Ribociclib|DRUG: Letrozole|DRUG: Ansastrozole|DRUG: Goserelin|DRUG: Leuprolide|DRUG: Exemestane
Sponsor: Novartis Pharmaceuticals